In addition, we do not see the same magnitude of cardiovascular risk reduction from equivalent weight loss from calorie restriction. In a published expert reaction to the SELECT trial, Tricia Tan, consultant in diabetes, endocrinology and metabolic medicine at Imperial College London and NHS Trust, highlighted the subsequent implication for National Institute for Health and Care Excellence (NICE) guidance, which currently recommends stopping semaglutide treatment in patients who have not lost more than 5% of weight after six months
Benefits of GLP-1 Drugs Significant weight loss: Users often lose 10-15% of their body weight Improved management of type 2 diabetes Reduced risk of cardiovascular events Potential savings in long-term healthcare costs Drawbacks and Concerns High cost: These drugs can cost over $1,000 per month without insurance Side effects: Nausea, vomiting, and gastrointestinal issues are common Long-term effects are still being studied Increased demand leading to drug shortages Impact on Health Insurance Premiums The rising popularity of GLP-1 drugs is affecting health insurance premiums: Some insurers report large double digit increases in pharmacy costs due to GLP-1 prescriptions This could lead to higher premiums for all policyholders However, long-term savings from reduced obesity-related health issues could offset these increases the data is still not comprehensive enough Are the Costs Worth It
Users will almost certainly have to contend with side effects including nausea, vomiting, abdominal pain, constipation, and diarrhea
Maybe one day we could make meat and other sources of L-carnitine in our diet safer to eat by developing a way to block the metabolism of this nutrient in the gut thereby lowering the risk of cardiovascular diseases
